Whalegun
Home

John Lunger, Chief Patient Supply Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 24/01/12

Trade details

Type
Insider sale
Amount
$4,437
Shares · price
5,220 sh · $0.85 a share
Held after
7,874 sh
Stock
Adaptimmune Therapeutics ADAPY
Person
John LungerChief Patient Supply Officer
Trade date
24/01/12
Filed
24/01/12
Days to filing
0 days

Sold 39.9% of holdings

Share of holding sold
39.9%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/13~24/02/11

John Lunger's recent trades

  • John Lunger

    SellAdaptimmune Therapeutics

    $3,239

    Filed 25/01/17

  • John Lunger

    Planned saleAdaptimmune Therapeutics

    $3,243

    Filed 25/01/17

  • John Lunger

    SellAdaptimmune Therapeutics

    $5,588

    Filed 25/01/15

  • John Lunger

    SellAdaptimmune Therapeutics

    $3,228

    Filed 25/01/15

  • John Lunger

    SellAdaptimmune Therapeutics

    $2,518

    Filed 25/01/15

John Lunger, Chief Officer — sold $4,437 of Adaptimmune Therapeutics ADAPY · 39.9% of holdings | Whalegun